Impact of age, race and socio-economic status on temporal trends in late-stage prostate cancer diagnosis in Florida

Spatial Statistics

Volumn 14, Issue , 2015, Pages 321-337

  Goovaerts, Pierre ^a   Xiao, Hong ^b   Gwede, Clement K ^c   Tan, Fei ^d   Huang, Youjie ^e   Adunlin, Georges ^f   Ali, Askal ^g  

^a BIOMEDWARE INC   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d INDIANA UNIVERSITY   (United States)

^e FLORIDA DEPARTMENT OF HEALTH   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Census tracts; Disparities; Joinpoint regression; PSA screening; Socio economic status

Indexed keywords

EID: 84949096952     PISSN: 22116753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spasta.2015.07.002     Document Type: Article

References (41)

1. Andriole G.L., Crawford E.D., Grubb R.L., Buys S.S., Chia D., Church T.R., Fouad M.N., Gelmann E.P., Kvale P.A., Reding D.J., Weissfeld J.L., Yokochi L.A., O'Brien B., Clapp J.D., Rathmell J.M., Riley T.L., Hayes R.B., Kramer B.S., Izmirlian G., Miller A.B., Pinsky P.F., Prorok P.C., Gohagan J.K., Berg C.D. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 2009, 360(13):1310-1319.
2. Barratt A.L., Stockler M.R. Screening for prostate cancer: Explaining new trial results and their implications to patients. Med. J. Aust. 2009, 191(4):226-229.
3. Bechis S.K., Carroll P.R., Cooperberg M.R. Impact of age at diagnosis on prostate cancer treatment and survival. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2011, 29(2):235-241.
4. Bernard J., Wilhelm N., Scherer M., May T., Schreck T. Time series paths: Projection-based explorative analysis of multivarate time series data. J. WSCG 2012, 20(2):97-106.
5. BioMedware, I., 2013. SpaceStat user manual version 4.1.
6. Brawn P.N., Johnson E.H., Kuhl D.L., Riggs M.W., Speights V., Johnson C.F., Pandya P.P., Lind M.L., Bell N.F. Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 1993, 71(8):2569-2573.
7. Carpenter W.R., Howard D.L., Taylor Y.J., Ross L.E., Wobker S.E., Godley P.A. Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control 2010, 21(7):1071-1080.
8. Chu K.C., Tarone R.E., Freeman H.P. Trends in prostate cancer mortality among black men and white men in the United States. Cancer 2003, 97(6):1507-1516.
9. Clegg L.X., Reichman M.E., Miller B.A., Hankey B.F., Singh G.K., Lin Y.D., Goodman M.T., Lynch C.F., Schwartz S.M., Chen V.W., Bernstein L., Gomez S.L., Graff J.J., Lin C.C., Johnson N.J., Edwards B.K. Impact of socioeconomic status on cancer incidence and stage at diagnosis: Selected findings from the surveillance, epidemiology, and end results: National longitudinal mortality study. Cancer Causes Control 2009, 20(4):417-435.
10. Do Y.K., Carpenter W.R., Spain P., Clark J.A., Hamilton R.J., Galanko J.A., Jackman A., Talcott J.A., Godley P.A. Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control 2010, 21(1):31-40.
11. Goovaerts P. Kriging and semivariogram deconvolution in the presence of irregular geographical units. Math. Geosci. 2008, 40(1):101-128.
12. Goovaerts P. Combining area-based and individual-level data in the geostatistical mapping of late-stage cancer incidence. Spat. Spat.-Temporal Epidemiol. 2009, 1(1):61-71.
13. Goovaerts P., Xiao H. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: A multiscale joinpoint regression analysis. Int. J. Health Geograph. 2011, 10(1):63.
14. Hayanga A.J., Kaiser H.E., Sinha R., Berenholtz S.M., Makary M., Chang D. Residential segregation and access to surgical care by minority populations in US counties. J. Am. Coll. Surg. 2009, 208(6):1017-1022.
15. Henry K.A., Boscoe F.P. Estimating the accuracy of geographical imputation. Int. J. Health Geograph. 2008, 7(1):3.
16. Hoffman R.M., Gilliland F.D., Eley J.W., Harlan L.C., Stephenson R.A., Stanford J.L., Albertson P.C., Hamilton A.S., Hunt W.C., Potosky A.L. Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study. J. Nat. Cancer Inst. 2001, 93(5):388-395.
17. Jones B.A., Liu W.L., Araujo A.B., Kasl S.V., Silvera S.N., Soler-Vila H., Curnen M.G., Dubrow R. Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol. Biomarkers Prevent. A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 2008, 17(10):2825-2834.
18. Kim H., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 2000, 19(3):335-351.
19. Kim H., Fay M.P., Yu B., Barrett M.J., Feuer E.J. Comparability of segmented line regression models. Biometrics 2004, 60(4):1005-1014.
20. Kim H.J., Yu B., Feuer E.J. Selecting the number of change-points in segmented line regression. Statist. Sinica 2009, 19(2):597-609.
21. Kruskal J.B. Multidimensional scaling by optimizing goodness of fit to a nonmetric hypothesis. Psychometrika 1964, 29:1-27.
22. Laiyemo A.O., Doubeni C., Pinsky P.F., Doria-Rose V.P., Bresalier R., Lamerato L.E., Crawford E.D., Kvale P., Fouad M., Hickey T., Riley T., Weissfeld J., Schoen R.E., Marcus P.M., Prorok P.C., Berg C.D. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J. Nat. Cancer Inst. 2010, 102(8):538-546.
23. Lerman P. Fitting segmented regression models by grid search. Appl. Stat. 1980, 29(8):77-84.
24. Lillo-Castellano J., Mora-Jiménez I., Santiago-Mozos R., Rojo-Álvarez J., Ramiro-Bargueño J., Algora-Weber A. Weaning outcome prediction from heterogeneous time series using normalized compression distance and multidimensional scaling. Expert Syst. Appl. 2013, 40(5):1737-1747.
25. Morton R.A. Racial differences in adenocarcinoma of the prostate in North American men. Urology 1994, 44(5):637-645.
26. Musa D., Schulz R., Harris R., Silverman M., Thomas S.B. Trust in the health care system and the use of preventive health services by older black and white adults. Am. J. Public Health 2009, 99(7):1293-1299.
27. Robbins A.S., Whittemore A.S., Thom D.H. Differences in socioeconomic status and survival among white and black men with prostate cancer. Am. J. Epidemiol. 2000, 151(4):409-416.
28. Salinas C.A., Tsodikov A., Ishak-Howard M., Cooney K.A. Prostate cancer in young men: An important clinical entity. Nat. Rev. Urol. 2014, 11(6):317-323.
29. SAS Institute Inc, 2011, SAS/STAT 9.3 User's guide, Cary, NC: SAS Institute Inc.
30. Schröder F.H., Hugosson J., Roobol M.J., Tammela T.L., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., Denis L.J., Recker F., Berenguer A., Määttänen L., Bangma C.H., Aus G., Villers A., Rebillard X., van der Kwast T., Blijenberg B.G., Moss S.M., de Koning H.J., Auvinen A. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 2009, 360(13):1320-1328.
31. Schwartz K.L., Crossley-May H., Vigneau F.D., Brown K., Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control 2003, 14(8):761-766.
32. Scosyrev E., Messing E.M., Mohile S., Golijanin D., Wu G. Prostate cancer in the elderly. Cancer 2012, 118(12):3062-3070.
33. Sheehan T.J., DeChello L.M., Kulldorff M., Gregorio D.I., Gershman S., Mroszczyk M. The geographic distribution of breast cancer incidence in massachusetts 1988 to 1997, adjusted for covariates. Int. J. Health Geograph. 2004, 3(1):17.
34. Shepard R. Representation of structure in similarity data: Problems and prospects. Psychometrika 1974, 39:373-421.
35. Smart C.R. The results of prostate carcinoma screening in the US as reflected in the surveillance, epidemiology, and end results program. Cancer 1997, 80(9):1835-1844.
36. Virnig B.A., Baxter N.N., Habermann E.B., Feldman R.D., Bradley C.J. A matter of race: Early versus late-stage cancer diagnosis. Health Aff. (Project Hope) 2009, 28(1):160-168.
37. Wachtel M.S., Nelius T., Haynes A.L., Dahlbeck S., de Riese W. PSA screening and deaths from prostate cancer after diagnosis-a population based analysis. Prostate 2013, 73:1365-1369.
38. Ward E.M., Fedewa S.A., Cokkinides V., Virgo K. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer Journal 2010, 16(6):614-621.
39. Webster R., Oliver M., Muir K., Mann J. Kriging the local risk of a rare disease from a register of diagnoses. Geogr. Anal. 1994, 26(2):168-185.
40. Wolf A.M., Wender R.C., Etzioni R.B., Thompson I.M., D'Amico A.V., Volk R.J., Brooks D.D., Dash C., Guessous I., Andrews K., DeSantis C., Smith R.A. American cancer society guideline for the early detection of prostate cancer: Update 2010. CA: Cancer J. Clin. 2010, 60(2):70-98.
41. Xiao H., Tan F., Goovaerts P., Adunlin G., Ali A., Huang Y., Gwede C.K. Factors associated with time-to-treatment of prostate cancer in Florida. J. Health Care Poor Underserved 2014, 24(4):132-146.